Sonoma Pharmaceuticals

2.37
开盘价
2.37
市值
4.10M+
最高价
2.39
最低价
2.13
收盘价
2.37
成交量
9.46K+
市盈率
-0.85
股息率
0.00%

Sonoma Pharmaceuticals简介

索诺马制药公司致力于开发和生产稳定的次氯酸(HOCl)产品,应用范围广泛,包括伤口护理、动物保健、眼睛护理、鼻部护理、口腔护理和皮肤病。它的产品以安全有效的方式引发感染、瘙痒、疼痛、结疤和有害的炎症反应。该公司由Hojabr Alimi和Linda Alimi于1999年4月创立,总部设在佐治亚州伍德斯托克。

如何购买 Sonoma Pharmaceuticals (SNOA)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 SNOA

购买 SNOA

通过 RockFlow App 或网页端搜索 SNOA,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.